Michael Powell - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Inozyme Pharma Inc (). Other recent insider transactions involving Inozyme Pharma Inc () include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc () in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc () were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Akouos Inc (). Other recent insider transactions involving Akouos Inc () include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc () were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.

Akouos Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Galera Therapeutics Inc (). Other recent insider transactions involving Galera Therapeutics Inc () include a net purchase of 932,402 shares made by , a net purchase of 100,000 shares made by Mel Sorensen , and a net purchase of 11,000 shares made by Mark Bachleda .

In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc () in total and bought 932,402 shares, with a net purchase of 932,402 shares. During the past 18 months, 0 shares of Galera Therapeutics Inc () were sold and 1,053,402 shares were bought by its insiders, resulting in a net purchase of 1,053,402 shares.

Galera Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Iterum Therapeutics PLC (). Other recent insider transactions involving Iterum Therapeutics PLC () include a net purchase of 55,000 shares made by Michael W. Dunne , a net purchase of 10,000 shares made by Fishman Corey N. , and a net sale of 3,365 shares made by Sailaja Puttagunta .

In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,365 shares of Iterum Therapeutics PLC () were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 61,635 shares.

Iterum Therapeutics PLC ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NextCure Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NextCure Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NextCure Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Synlogic Inc (). Other recent insider transactions involving Synlogic Inc () include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .

In summary, during the past 3 months, insiders sold 560 shares of Synlogic Inc () in total and bought 0 shares, with a net sale of 560 shares. During the past 18 months, 28,593 shares of Synlogic Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,593 shares.

Synlogic Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Entasis Therapeutics Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Marinus Pharmaceuticals Inc (). Other recent insider transactions involving Marinus Pharmaceuticals Inc () include a net sale of 6,443 shares made by Scott Braunstein , a net sale of 2,902 shares made by Joseph Hulihan , and a net sale of 2,804 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,566 shares of Marinus Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,566 shares.

Marinus Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Aclaris Therapeutics Inc (). Other recent insider transactions involving Aclaris Therapeutics Inc () include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net sale of 95,100 shares made by Andrew N Schiff .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 284,338 shares of Aclaris Therapeutics Inc () were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 247,343 shares.

Aclaris Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in aTyr Pharma Inc (). Other recent insider transactions involving aTyr Pharma Inc () include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 1,590 shares of aTyr Pharma Inc () in total and bought 0 shares, with a net sale of 1,590 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc () were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.

aTyr Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Spark Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spark Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spark Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Ocugen Inc (). Other recent insider transactions involving Ocugen Inc () include a net sale of 295,809 shares made by Shankar Musunuri , and a net purchase of 200,278 shares made by Junge Zhang .

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,809 shares of Ocugen Inc () were sold and 200,278 shares were bought by its insiders, resulting in a net sale of 95,531 shares.

Ocugen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Alimera Sciences Inc (). Other recent insider transactions involving Alimera Sciences Inc () include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc () were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.

Alimera Sciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Humanigen Inc (). Other recent insider transactions involving Humanigen Inc () include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anthera Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anthera Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anthera Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Amarin Corp PLC (). Other recent insider transactions involving Amarin Corp PLC () include a net purchase of 314,426 shares made by Patrick Holt , and a net sale of 34,131 shares made by Steven B Ketchum .

In summary, during the past 3 months, insiders sold 0 shares of Amarin Corp PLC () in total and bought 14,426 shares, with a net purchase of 14,426 shares. During the past 18 months, 34,131 shares of Amarin Corp PLC () were sold and 314,426 shares were bought by its insiders, resulting in a net purchase of 280,295 shares.

Amarin Corp PLC ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Molecular Templates Inc (). Other recent insider transactions involving Molecular Templates Inc () include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc () in total and bought 250,000 shares, with a net purchase of 250,000 shares. During the past 18 months, 0 shares of Molecular Templates Inc () were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Paratek Pharmaceuticals Inc (). Other recent insider transactions involving Paratek Pharmaceuticals Inc () include a net sale of 181,011 shares made by Evan Loh , a net sale of 104,375 shares made by Michael Bigham , and a net sale of 83,909 shares made by William M. Haskel .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 469,621 shares of Paratek Pharmaceuticals Inc () were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 318,879 shares.

Paratek Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Seagen Inc (). Other recent insider transactions involving Seagen Inc () include a net sale of 36,447 shares made by Jean I Liu , a net sale of 46,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 413,479 shares of Seagen Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 413,479 shares.

Seagen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Bolt Biotherapeutics Inc (). Other recent insider transactions involving Bolt Biotherapeutics Inc () include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .

In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc () were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.

Bolt Biotherapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Vera Therapeutics Inc (). Other recent insider transactions involving Vera Therapeutics Inc () include a net purchase of 441,721 shares made by Beth C Seidenberg , a net sale of 27,690 shares made by Joanne Curley , and a net sale of 99,192 shares made by Sean Grant .

In summary, during the past 3 months, insiders sold 958,650 shares of Vera Therapeutics Inc () in total and bought 161,290 shares, with a net sale of 797,360 shares. During the past 18 months, 2,043,040 shares of Vera Therapeutics Inc () were sold and 4,784,797 shares were bought by its insiders, resulting in a net purchase of 2,741,757 shares.

Vera Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.